Literature DB >> 24763550

Physician and Patient and Caregiver Health Attitudes and Their Effect on Medicare Resource Allocation for Patients With Advanced Cancer.

Daniel J Rocke1, Halton W Beumer2, Donald H Taylor3, Steven Thomas4, Liana Puscas1, Walter T Lee5.   

Abstract

IMPORTANCE: Physicians must participate in end-of-life discussions, but they understand poorly their patients' end-of-life values and preferences. A better understanding of these preferences and the effect of baseline attitudes will improve end-of-life discussions.
OBJECTIVE: To determine how baseline attitudes toward quality vs quantity of life affect end-of-life resource allocation. DESIGN, SETTING, AND PARTICIPANTS: Otolaryngology-head and neck surgery (OHNS) physicians were recruited to use a validated online tool to create a Medicare health plan for advanced cancer patients. During the exercise, participants allocated a limited pool of resources among 15 benefit categories. These data were compared with preliminary data from patients with cancer and their caregivers obtained from a separate study using the same tool. Attitudes toward quality vs quantity of life were assessed for both physicians and patients and caregivers.
INTERVENTIONS: Participation in online assessment exercise. MAIN OUTCOMES AND MEASURES: Medicare resource allocation.
RESULTS: Of 9120 OHNS physicians e-mailed, 767 participated. Data collected from this group were compared with data collected from 146 patients and 114 caregivers. Compared with patients and caregivers, OHNS physician allocations differed significantly in all 15 benefit categories except home care. When stratified by answers to 3 questions about baseline attitudes toward quality vs quantity of life, there were 3 categories in which allocations of patients and caregivers differed significantly from the group with the opposite attitude for at least 2 questions: other medical care (question 1, P < .001; question 2, P = .005), palliative care (question 1, P = .008; question 2, P = .006; question 3, P = .009), and treatment for cancer (questions 1 and 2, P < .001). In contrast, physician preferences showed significant differences in only 1, nonmatching category for each attitude question: cash (question 1, P = .02), drugs (question 2, P = .03), and home care (question 3, P = .048). CONCLUSIONS AND RELEVANCE: Patients with cancer and their caregivers have different preferences from physicians. These preferences are, for these patients and their caregivers, affected by their baseline health attitudes, but physician preferences are not. Understanding the effect of baseline attitudes is important for effective end-of-life discussions.

Entities:  

Mesh:

Year:  2014        PMID: 24763550      PMCID: PMC4514572          DOI: 10.1001/jamaoto.2014.494

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  19 in total

1.  Psychological responses of patients receiving a diagnosis of cancer.

Authors:  P E Schofield; P N Butow; J F Thompson; M H N Tattersall; L J Beeney; S M Dunn
Journal:  Ann Oncol       Date:  2003-01       Impact factor: 32.976

2.  Surgeons' decisions and the financial and human costs of medical care.

Authors:  Mark D Neuman
Journal:  N Engl J Med       Date:  2010-12-16       Impact factor: 91.245

3.  Choosing Healthplans All Together: a deliberative exercise for allocating limited health care resources.

Authors:  Susan Dorr Goold; Andrea K Biddle; Glenn Klipp; Charles N Hall; Marion Danis
Journal:  J Health Polit Policy Law       Date:  2005-08       Impact factor: 2.265

Review 4.  Value of high-cost cancer care: a behavioral science perspective.

Authors:  Kevin P Weinfurt
Journal:  J Clin Oncol       Date:  2007-01-10       Impact factor: 44.544

5.  Patients' values and clinical substituted judgments: the case of localized prostate cancer.

Authors:  Arthur S Elstein; Gretchen B Chapman; Sara J Knight
Journal:  Health Psychol       Date:  2005-07       Impact factor: 4.267

6.  Knowledge and attitudes toward end-of-life care in veterans with symptomatic metastatic cancer.

Authors:  Shirley S Hwang; Victor T Chang; Janet Cogswell; Shanthi Srinivas; Basil Kasimis
Journal:  Palliat Support Care       Date:  2003-09

7.  How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies.

Authors:  Darius N Lakdawalla; John A Romley; Yuri Sanchez; J Ross Maclean; John R Penrod; Tomas Philipson
Journal:  Health Aff (Millwood)       Date:  2012-04       Impact factor: 6.301

8.  Cancer patient preferences for quality and length of life.

Authors:  Neal J Meropol; Brian L Egleston; Joanne S Buzaglo; Al B Benson; Donald J Cegala; Michael A Diefenbach; Linda Fleisher; Suzanne M Miller; Daniel P Sulmasy; Kevin P Weinfurt
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

9.  Physician factors associated with discussions about end-of-life care.

Authors:  Nancy L Keating; Mary Beth Landrum; Selwyn O Rogers; Susan K Baum; Beth A Virnig; Haiden A Huskamp; Craig C Earle; Katherine L Kahn
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

10.  Patient involvement in decisions to limit treatment: the crucial role of agreement between physician and patient.

Authors:  Eva C Winkler; Stella Reiter-Theil; Dorothee Lange-Riess; Nina Schmahl-Menges; Wolfgang Hiddemann
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544

View more
  1 in total

1.  Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population.

Authors:  Tatiana Dilla; Luís Lizan; Silvia Paz; Pilar Garrido; Cristina Avendaño; Juan J Cruz-Hernández; Javier Espinosa; José A Sacristán
Journal:  Patient Prefer Adherence       Date:  2015-12-18       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.